CRSP position history
The shares of Crispr Therapeutics (CRSP) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 44,625 shares, $2.2M, 0.46% of portfolio, New
- 2025 Q3: 41,226 shares, $2.7M, 0.49% of portfolio, Reduce −7.6%
- 2025 Q4: 41,226 shares, $2.2M, 0.30% of portfolio
- 2026 Q1: 39,605 shares, $1.9M, 0.29% of portfolio, Reduce −3.9%
- 2026 Q2: 39,605 shares, $2.2M, 0.30% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|